Get started
Author

U. Basu Roy

Observed name: Upal Basu Roy
Observed institution: LUNGevity Foundation
ORCID: 0000-0002-1523-8017
Observed ORCID: 0000-0002-1523-8017
OpenAlex ID: A5036605889
OA03.03 The 2024 International Association for the Study of Lung Cancer (IASLC) Global Survey on Biomarker Testing
2024 · M. Smeltzer, C. Connolly, et al. · Journal of Thoracic Oncology · 4
MA07.08 Needs Assessment of Lung Cancer Patients & Caregivers in the Post-Shelter-in-Place Era in the United States during COVID-19
2021 · U. Basu Roy, M. Jacobson, et al. · Journal of Thoracic Oncology · 1
PDF
P1.17.24 Mixed Methods IASLC Global Survey and Provider Interview Study of Us NSCLC Biomarker Testing Practices and Clinical Processes
2025 · J. Chen, N. Tripathi, et al. · Journal of Thoracic Oncology
MA06.09 Assessing the Impact of Project ASCENT, a Multi-Level Lung Cancer Screening Intervention Targeting Hispanic/Latin Individuals
2025 · L. Spiegelman, F.N.A. Mustafayev, et al. · Journal of Thoracic Oncology
101P: European results from the 2024 International Association for the Study of Lung Cancer (IASLC) global survey on biomarker testing
2025 · M.P. Smeltzer, C. Connolly, et al. · Journal of Thoracic Oncology
PDF
OA01.06 Project PEER: A Longitudinal Real-World Study to Understand the Experience of Patients with Lung Cancer and Their Caregivers
2022 · U. Basu Roy, A.-M. Baird, et al. · Journal of Thoracic Oncology
Patient concerns during the COVID-19pandemic: Lessons from the lung cancer community
2020 · Janet Freeman‐Daily, U. Basu Roy, et al. · Clinical Cancer Research
Collaborating to share evidence-basedCOVID-19 information across lung cancer patientadvocacy groups
2020 · A. C. Moore, Janet Freeman‐Daily, et al. · Clinical Cancer Research
A Comprehensive Survey of Managed Care Organization (MCO) Medication Adherence Intervention Programs
2016 · Clifford Jones, Fawad Piracha, et al. · Iproceedings
Works count: 9
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type